Startling Admissions in IVF Journal
By Michael Cook,
BioEdge
| 08. 04. 2012
Some IVF patients are being offered risky, unsafe techniques which have not been developed with clinical trial and which offer dubious benefits, according to
an extraordinary article in the journal Reproductive BioMedicine Online (RBO). Writing in the journal founded by Robert Edwards, who won a Nobel Prize for developing IVF, two British scientists have made a devastating critique of the IVF industry. Rachel Brown and Joyce Harper, of University College London, say:
“In 1978, the first child conceived by IVF was born. In the following 33 years, numerous technologies and techniques have been developed ... However, these techniques have rarely been robustly tested and approved before they are routinely offered to infertile couples. In other cases, a development in our scientific understanding of a technique has failed to be quickly incorporated into clinical changes. This raises the concern that some of the techniques offered to some patients offer little or no benefit, and in the worse cases is not confirmed to be safe.”
Brown and Harper worry that even riskier techniques -- such as artifical gametes -- are being...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...